CONMED CORPORATION Write off of Deferred Debt Issuance Cost
CONMED CORPORATION (CNMD) reported Write off of Deferred Debt Issuance Cost of $363.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2026-02-17
- CONMED CORPORATION write off of deferred debt issuance cost for the quarter ending 2025-12-31 was $0.00.
- CONMED CORPORATION write off of deferred debt issuance cost for the quarter ending 2025-09-30 was $0.00.
- CONMED CORPORATION write off of deferred debt issuance cost for the quarter ending 2024-12-31 was $0.00.
- CONMED CORPORATION write off of deferred debt issuance cost for the quarter ending 2024-09-30 was $0.00.
- CONMED CORPORATION write off of deferred debt issuance cost for fiscal 2025 was $363.00K.
- CONMED CORPORATION write off of deferred debt issuance cost for fiscal 2024 was $0.00.
- CONMED CORPORATION write off of deferred debt issuance cost for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CONMED CORPORATION write off of deferred debt issuance cost for fiscal 2022 was $3.43M, a 281.09% increase from fiscal 2021.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 6 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $363.00K 10-K · filed 2026-02-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $363.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $363.00K 10-Q · filed 2025-07-31 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-07-31 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-07-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $3.43M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $3.43M 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | $3.43M 10-Q · filed 2023-07-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $899.00K derived: sum of 2 quarters · filed 2024-02-28 | $899.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $899.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $899.00K 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-07-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |